{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:44:31Z","timestamp":1769629471565,"version":"3.49.0"},"reference-count":16,"publisher":"Informa UK Limited","issue":"4-5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["HIV Research & Clinical Practice"],"published-print":{"date-parts":[[2019,9,3]]},"DOI":"10.1080\/25787489.2020.1716159","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T07:03:46Z","timestamp":1580454226000},"page":"107-110","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens"],"prefix":"10.1080","volume":"20","author":[{"given":"Francesca","family":"Ferretti","sequence":"first","affiliation":[{"name":"Department of HIV, Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola E.","family":"Mackie","sequence":"additional","affiliation":[{"name":"Department of HIV, Sexual Health and Infections, Imperial College Healthcare NHS Trust, London, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurmit Kaur Jagjit","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of HIV, Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Fox","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas Hospital NHS Foundation Trust, London, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-4741","authenticated-orcid":false,"given":"Steve","family":"Kaye","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra O.","family":"McClure","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Taylor","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Boffito","sequence":"additional","affiliation":[{"name":"Department of HIV, Sexual Health, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK;"},{"name":"Division of Infectious Diseases, Imperial College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"2","key":"e_1_3_2_2_1","first-page":"188","article-title":"Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study","volume":"18","author":"Venter WDF","year":"2017","unstructured":"Venter WDF, Moorhouse M, Grobbee DE, et\u00a0al. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2017;18(2):188\u2013197.","journal-title":"Lancet Infect Dis."},{"issue":"3","key":"e_1_3_2_3_1","first-page":"5072","article-title":"Low level viremia is associated with virologic failure in a large military cohort","volume":"61","author":"Joya C","year":"2015","unstructured":"Joya C, Won SH, Okulicz J, et\u00a0al. Low level viremia is associated with virologic failure in a large military cohort. Clin Infect Dis. 2015;61(3):5072.","journal-title":"Clin Infect Dis."},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.15.9625-9634.2005"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.7.817"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2017.07.010"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2016.08.012"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000344"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832cbcec"},{"issue":"10","key":"e_1_3_2_10_1","first-page":"2339","article-title":"Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: A clinical cohort study","volume":"68","author":"Dolling DI","year":"2013","unstructured":"Dolling DI, UK Collaborative HIV Cohort Study (UK CHIC), Dunn DT, et\u00a0al. Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: A clinical cohort study. J Antimicrob Chemother. 2013;68(10):2339\u20132343.","journal-title":"J Antimicrob Chemother."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010952"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030118"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx366"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Fun A Wensing AMJ Verheyen J Nijhuis M. Human immunodeficiency virus gag and protease: partners in resistance (Figure 1). 2012;1\u201314. http:\/\/www.retrovirology.com\/content\/pdf\/1742-4690-9-63.pdf","DOI":"10.1186\/1742-4690-9-63"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz043"},{"key":"e_1_3_2_16_1","first-page":"1","article-title":"Use of next-generation sequencing in the CHAT study (acute HCV in HIV): effect of baseline resistance-associated NS3 variants on treatment failure","volume":"4336","author":"Rockstroh J","year":"2018","unstructured":"Rockstroh J, Boesecke C, McClure MO, et\u00a0al. Use of next-generation sequencing in the CHAT study (acute HCV in HIV): effect of baseline resistance-associated NS3 variants on treatment failure. HIV Clin Trials. 2018;4336:1\u20136.","journal-title":"HIV Clin Trials."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku296"}],"container-title":["HIV Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/25787489.2020.1716159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:00:52Z","timestamp":1717599652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/25787489.2020.1716159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":16,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2019,9,3]]}},"alternative-id":["10.1080\/25787489.2020.1716159"],"URL":"https:\/\/doi.org\/10.1080\/25787489.2020.1716159","relation":{},"ISSN":["2578-7489","2578-7470"],"issn-type":[{"value":"2578-7489","type":"print"},{"value":"2578-7470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}